Evidence map›Paper›PMID 28469428›Full record

ArticleBiomedical informatics insights2017

Using Electronic Medical Record to Identify Patients With Dyslipidemia in Primary Care Settings: International Classification of Disease Code Matters From One Region to a National Database.

Justin Oake, Erfan Aref-Eshghi, Marshall Godwin, Kayla Collins, Kris Aubrey-Bassler, Pauline Duke, Masoud Mahdavian, Shabnam Asghari

Abstract read
In one paragraph

Article in Biomedical informatics insights, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. ANMCO position paper E-health integration in cardiology clinical care framework.European heart journal supplements : journal of the European Society of Cardiology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Justin OakeCentre for Rural Health Studies, Faculty of Medicine, Memorial University of Newfoundland St. John's, NL, Canada.
Erfan Aref-EshghiCentre for Rural Health Studies, Faculty of Medicine, Memorial University of Newfoundland St. John's, NL, Canada.
Marshall GodwinCentre for Rural Health Studies, Faculty of Medicine, Memorial University of Newfoundland St. John's, NL, Canada.
Kayla CollinsNewfoundland and Labrador Centre for Health Information, St. John's, NL, Canada.
Kris Aubrey-BasslerCentre for Rural Health Studies, Faculty of Medicine, Memorial University of Newfoundland St. John's, NL, Canada.
Pauline DukeCentre for Rural Health Studies, Faculty of Medicine, Memorial University of Newfoundland St. John's, NL, Canada.
Masoud MahdavianDepartment of Medicine, Faculty of Medicine, Memorial University of Newfoundland, St. John's, NL, Canada.
Shabnam AsghariCentre for Rural Health Studies, Faculty of Medicine, Memorial University of Newfoundland St. John's, NL, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo assess the validity of the International Classification of Disease (ICD) codes for identifying patients with dyslipidemia in electronic medical record (EMR) data.

methodsThe EMRs of patients receiving primary care in St. John's, Newfoundland and Labrador (NL), Canada, were retrieved from the Canadian Primary Care Sentinel Surveillance Network database. International Classification of Disease codes were first compared with laboratory lipid data as an independent criterion standard, and next with a "comprehensive criterion standard," defined as any existence of abnormal lipid test, lipid-lowering medication record, or dyslipidemia ICD codes. The ability of ICD coding alone or combined with other components was evaluated against the two criterion standards using receiver operating characteristic (ROC) analysis, sensitivity, specificity, negative predictive value (NPV) and Kappa agreement. (No specificity was reported for the comparison of ICD codes against the comprehensive criterion standard as this naturally leads to 100% specificity.).

resultsThe ICD codes led to a poor outcome when compared with the serum lipid levels (sensitivity, 27%; specificity, 76%; PPV, 71%; NPV, 33%; Kappa, 0.02; area under the receiver operating characteristic curve (AUC), 0.51) or with the comprehensive criterion standard (sensitivity, 32%; NPV, 25%; Kappa, 0.15; AUC, 66%). International Classification of Disease codes combined with lipid-lowering medication data also resulted in low sensitivity (51.2%), NPV (32%), Kappa (0.28), and AUC (75%). The addition of laboratory lipid levels to ICD coding marginally improved the algorithm (sensitivity, 94%; NPV, 79%; Kappa, 0.85; AUC, 97%).

conclusionsThe use of ICD coding, either alone or in combination with laboratory data or lipid-lowering medication records, was not an accurate indicator in identifying dyslipidemia.

Indexed as

algorithmdyslipidemiaelectronic medical recordsICD codesvalidation

Identifiers

PMID28469428
PMCPMC5391192

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.